Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.06 from other evidence | 0.00 |
| cell type Human Protein Atlas | enriched in the midbrain (17 nTPM), where the nigral dopamine neurons sit | 0.90 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 15 Parkinson's papers of 513 | 0.64 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 4475
Sealed predictions
- EN2 in dopamine neurons, braak-0.03 (p 0.929) → -0.34 (p 0.369)receipt 4480
Swarm cases
receipt 4480: EN2 in dopamine neurons, braak
- power
- full sample -0.23 (p 0.369, n 18), 95% CI -0.63 to +0.27. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.28 (p 0.258, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.37 (p 0.135, n 18). could be the mix.
- skeptic
- leave-one-out range -0.38 to -0.13, sign flips 0; without severely affected donors -0.23 (p 0.369, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for EN2 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts